Nintedanib Capsule
Product Images NDC 69097-641
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nintedanib (NDC 69097-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 03)
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 04)
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 05)
This is a statistical analysis report evaluating the impact of a drug called Nintedanib on the decline of Forced Vital Capacity (FVC) over 52 weeks compared to a placebo. The report includes estimates, population size, averages, confidence intervals, and comparisons of outcomes between the Nintedanib group and the placebo group. The data suggests that Nintedanib may have a beneficial effect on FVC decline compared to the placebo.*
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 06)
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 07)
Bottle-100mg-label-kkb (Bottle 100mg Label Kkb)
Container-150mg-label-kkb (Container 150mg Label Kkb)
Figure-7 (Figure 7)
Figure-8 (Figure 8)
Figure-9 (Figure 9)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.